KLINGEMANN HANS has a total of 11 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and basic materials chemistry are AVIDITY BIOSCIENCES INC, AVIDITY BIOSCIENCES LLC and NKBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Klingemann Hans | 11 |
Publication | Filing date | Title |
---|---|---|
US2016113966A1 | Composition and methods of culture supernatant of khyg-1 cells | |
US2014314872A1 | Methods of Use of Culture Supernatant Obtained from Mesenchymal Stem Cells from Dogs and Cats for Treatment of Organ Dysfunction | |
US2014099714A1 | Natural killer cell lines and methods of use | |
CA2289915A1 | Natural killer cell lines and methods of use | |
AU7267398A | Natural killer cell lines and methods of use |